D. Beauchamp

发表

Reduction of gentamicin nephrotoxicity by the concomitant administration of poly-l-aspartic acid and poly-l-asparagine in rats.

G. Laurent, P. Tulkens, P. Maldague, 1986, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

Epidermal growth factor accelerates renal tissue repair in a model of gentamicin nephrotoxicity in rats.

M. Bergeron, G. Laurent, D. Nonclercq, 1992, The American journal of physiology.

Potentiation of gentamicin nephrotoxicity in the rat by infusion of aprotinin.

M. Bergeron, G. Laurent, D. Nonclercq, 1994, Experimental and molecular pathology.

Attenuation of gentamicin-induced nephrotoxicity in rats by fleroxacin

M. Bergeron, G. Laurent, L. Grenier, 1997, Antimicrobial agents and chemotherapy.

In Vivo Activity and Pharmacokinetics of Ziracin (SCH27899), a New Long-Acting Everninomicin Antibiotic, in a Murine Model of Penicillin-Susceptible or Penicillin-Resistant Pneumococcal Pneumonia

M. Bergeron, Y. Bergeron, M. Simard, 2000, Antimicrobial Agents and Chemotherapy.

Pharmacologic basis for the treatment of pyelonephritis

M. Bergeron, D. Beauchamp, 1999, Current infectious disease reports.

Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2',3'-dideoxyinosine

M. Bergeron, P. Harvie, D. Beauchamp, 1996, Antimicrobial agents and chemotherapy.

Time-restricted feeding schedules modify temporal variation of gentamicin experimental nephrotoxicity

M. Bergeron, D. Tardif, L. Grenier, 1997, Antimicrobial agents and chemotherapy.

Effects of fasting on temporal variations in nephrotoxicity of gentamicin in rats

M. Bergeron, L. Grenier, D. Beauchamp, 1996, Antimicrobial agents and chemotherapy.

Nephrotoxicity of amphotericin B in rats: effects of the time of administration.

M. Bergeron, L. Grenier, D. Beauchamp, 1996, Life sciences.

Comparison of cellular accumulation, tissue distribution, and anti-HIV activity of free and liposomal 2',3'-dideoxycytidine.

M. Bergeron, M. Tremblay, D. Beauchamp, 1994, AIDS research and human retroviruses.

Daptomycin may attenuate experimental tobramycin nephrotoxicity by electrostatic complexation to tobramycin

M. Bergeron, D. Carrier, M. Simard, 1994, Antimicrobial Agents and Chemotherapy.

Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling

M. Bergeron, M. Simard, D. Beauchamp, 1992, Antimicrobial Agents and Chemotherapy.

Subcellular distribution of gentamicin in proximal tubular cells, determined by immunogold labeling

M. Bergeron, D. Beauchamp, P. Gourde, 1991, Antimicrobial Agents and Chemotherapy.

Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada

M. Bergeron, N. Rousseau, M. Picard, 1992, Antimicrobial Agents and Chemotherapy.

Increased nephrotoxicity of gentamicin in pyelonephritic rats.

M. Bergeron, D. Beauchamp, A. Poirier, 1985, Kidney international.

Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo.

M. Bergeron, D. Beauchamp, A. Bastille, 1981, Reviews of infectious diseases.

Ceftriaxone protects against tobramycin nephrotoxicity

M. Bergeron, Y. Bergeron, L. Grenier, 1994, Antimicrobial Agents and Chemotherapy.

Protein-rich diet attenuates cyclosporin A-induced renal tubular damage in rats.

I. Plante, M. Simard, L. Grenier, 2003, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Protection against gentamicin nephrotoxicity by daptomycin in nephrectomized rats.

M. Bergeron, M. Simard, L. Grenier, 1995, Life sciences.

Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity

M. Bergeron, M. Simard, L. Grenier, 1994, Antimicrobial Agents and Chemotherapy.

Subcellular distribution of daptomycin given alone or with tobramycin in renal proximal tubular cells

M. Bergeron, M. Simard, D. Beauchamp, 1994, Antimicrobial Agents and Chemotherapy.

Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9.

M. Bergeron, M. Tremblay, D. Beauchamp, 1999, Sexually transmitted diseases.

Pulmonary and Systemic Host Response to Streptococcus pneumoniae and Klebsiella pneumoniae Bacteremia in Normal and Immunosuppressed Mice

M. Bergeron, Y. Bergeron, N. Ouellet, 2001, Infection and Immunity.

Pathogenesis of Pneumococcal Pneumonia in Cyclophosphamide-Induced Leukopenia in Mice

M. Bergeron, Y. Bergeron, N. Ouellet, 2002, Infection and Immunity.

Prolonged endotoxemia enhances the renal injuries induced by gentamicin in rats

M. Bergeron, D. Tardif, D. Beauchamp, 1990, Antimicrobial Agents and Chemotherapy.

Protective effect of fleroxacin against the nephrotoxicity of isepamicin in rats.

D. Beauchamp, Y. Yoshiyama, M. Kanke, 2002, Biological & pharmaceutical bulletin.

Temporal variation in nephrotoxicity of low doses of isepamicin in rats

M. Bergeron, M. Simard, L. Grenier, 1996, Antimicrobial agents and chemotherapy.

Temporal changes of pharmacokinetics, nephrotoxicity, and subcellular distribution of tobramycin in rats

M. Bergeron, Y. Bergeron, M. Simard, 1994, Antimicrobial Agents and Chemotherapy.

L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis

M. Bergeron, Y. Bergeron, D. Beauchamp, 1994, Antimicrobial Agents and Chemotherapy.

Increased renal uptake of gentamicin in endotoxemic rats receiving concomitant thromboxane A2 antagonist therapy

M. Bergeron, Y. Bergeron, D. Beauchamp, 1993, Antimicrobial Agents and Chemotherapy.

Dietary composition alters gentamicin-induced nephrotoxicity in rats

I. Plante, D. Beauchamp, L. Thibault, 2002, Physiology & Behavior.

Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats

M. Bergeron, M. Pellerin, D. Beauchamp, 1990, Antimicrobial Agents and Chemotherapy.

Modification in penicillin-binding proteins during in vivo development of genetic competence of Haemophilus influenzae is associated with a rapid change in the physiological state of cells

M. Jacques, F. Malouin, D. Beauchamp, 1992, Infection and immunity.

Influence of hydrocortisone on gentamicin-induced nephrotoxicity in rats

D. Beauchamp, M. Pettigrew, 1988, Antimicrobial Agents and Chemotherapy.

Molecular Basis oftheNon-1B-Lactamase-Mediated Resistance to13-Lactam Antibiotics inStrains of Haemophilus influenzae Isolated inCanada

M. Bergeron, N. Rousseau, N. Clairoux, 1992 .

Effectiveness and Toxicity of Gentamicin in an Experimental Model of Pyelonephritis: Effect of the Time of Administration

M. Bergeron, L. Grenier, D. Beauchamp, 1999, Antimicrobial Agents and Chemotherapy.

Endotoxin increases the nephrotoxic potential of gentamicin and vancomycin plus gentamicin.

M. Bergeron, D. Tardif, D. Beauchamp, 1990, The Journal of infectious diseases.

Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model.

M. Bergeron, M. Tremblay, P. Harvie, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Renal Phospholipidosis and Cellular-response of Diabetic and Control Rats To Low Nontoxic Doses of Gentamicin-(g)

G. Laurent, P. Tulkens, C. Vaamonde, 1986 .

Reducing chorioretinal viral counts with intravitreal foscarnet injections in a rabbit model of Herpes simplex virus type-1 retinitis.

M. Bergeron, M. Tremblay, A. Rousseau, 1999, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet

M. Bergeron, M. Tremblay, N. Dusserre, 1995, Antimicrobial agents and chemotherapy.

Dietary protein level alters gentamicin-induced nephrotoxicity in rats

N. Zeeni, D. Beauchamp, B. Selmaoui, 2007, Physiology & Behavior.

Efficacy of Gel Formulations Containing free and Liposomal Foscarnet in a Murine Model of Cutaneous HSV-1 Infection

M. Bergeron, M. Tremblay, D. Beauchamp, 1999 .

Effect of Fasting on Temporal Variation in the Nephrotoxicity of Amphotericin B in Rats

M. Bergeron, L. Grenier, D. Beauchamp, 1999, Antimicrobial Agents and Chemotherapy.

Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment

M. Bergeron, M. Simard, D. Beauchamp, 1997, Antimicrobial agents and chemotherapy.

Aminoglycoside nephrotoxicity: do time and frequency of administration matter?

D. Beauchamp, G. Labrecque, 2001, Current opinion in critical care.

Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia.

M. Bergeron, Y. Bergeron, N. Ouellet, 2000, The Journal of infectious diseases.

Chronobiology and chronotoxicology of antibiotics and aminoglycosides.

D. Beauchamp, G. Labrecque, 2007, Advanced drug delivery reviews.

Azithromycin uptake and intracellular accumulation by Toxoplasma gondii-infected macrophages.

D. Beauchamp, J. Blais, S. Chamberland, 1994, The Journal of antimicrobial chemotherapy.

Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti‐HIV-1 activity, tissue distribution, and pharmacokinetics

M. Bergeron, D. Beauchamp, S. Perron, 1995, AIDS.

Effect of beta-lactams on peptidoglycan metabolism of Haemophilus influenzae grown in animals

N. Rousseau, F. Malouin, D. Beauchamp, 1992, Antimicrobial Agents and Chemotherapy.

Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in the murine AIDS model.

M. Bergeron, M. Tremblay, P. Harvie, 1997, Toxicology and applied pharmacology.

Circadian Variation in the Intracortical Accumulation Kinetics of Tobramycin in Conscious Rats

M. Bergeron, L. Grenier, D. Beauchamp, 1995 .

The effect of fosfomycin on glycopeptide antibiotic-induced nephrotoxicity in rats

D. Beauchamp, Y. Yoshiyama, M. Kanke, 2001, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Relationship between intrarenal distribution and efficacy of fleroxacin in the treatment ofEscherichia coli pyelonephritis in rats

M. Bergeron, D. Beauchamp, N. J. Morin, 1998 .

Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.

G. Laurent, P. Tulkens, P. Maldague, 1990, The Journal of pharmacology and experimental therapeutics.

Disturbed intrarenal distribution of gentamicin in experimental pyelonephritis due to Escherichia coli.

S. Trottier, M. Bergeron, D. Beauchamp, 1982, The Journal of infectious diseases.

Epstein-Barr virus infects and induces apoptosis in human neutrophils.

L. Flamand, D. Beauchamp, P. Gourde, 1998, Blood.

Nephrotoxicity of teicoplanin in rats.

D. Beauchamp, Y. Yoshiyama, M. Kanke, 2000, The Japanese journal of antibiotics.

Influence of endotoxin on the intracortical accumulation kinetics of gentamicin in rats

M. Bergeron, D. Tardif, D. Beauchamp, 1990, Antimicrobial Agents and Chemotherapy.

Intrarenal distribution of vancomycin in endotoxemic rats

M. Bergeron, D. Tardif, D. Beauchamp, 1989, Antimicrobial Agents and Chemotherapy.

Influence of hydrocortisone succinate on intrarenal accumulation of gentamicin in endotoxemic rats

M. Bergeron, Y. Bergeron, D. Beauchamp, 1987, Antimicrobial Agents and Chemotherapy.

Influence of indomethacin on the intrarenal uptake of gentamicin in endotoxemic rats

M. Bergeron, Y. Bergeron, D. Beauchamp, 1989, Antimicrobial Agents and Chemotherapy.

Temporal modulation of nephrotoxicity, feeding, and drinking in gentamicin-treated rats

D. Beauchamp, L. Thibault, G. Labrecque, 2000, Physiology & Behavior.

Uptake and binding of liposomal 2',3'-dideoxycytidine by RAW 264.7 cells: a three-step process.

M. Bergeron, M. Tremblay, D. Beauchamp, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

In vivo toxicity of foscarnet and zidovudine given alone or in combination.

M. Bergeron, M. Tremblay, D. Beauchamp, 1996, Toxicology and applied pharmacology.

Comparative Pharmacokinetics , Distributions in Tissue , and Interactions with Blood Proteins of Conventional and Sterically Stabilized Liposomes Containing 2 9 , 3 9 -

M. Bergeron, M. Tremblay, D. Beauchamp, 1995 .

Lymphoid tissues targeting of liposome‐encapsulated 2/,3/-dideoxyinosine

M. Bergeron, D. Beauchamp, A. Désormeaux, 1995, AIDS.

Circadian Rhythms in Infectious Diseases: Do They Matter?

D. Beauchamp, G. Labrecque, 1999 .

Molecular basis of the inhibition of gentamicin nephrotoxicity by daptomycin; an infrared spectroscopic investigation.

M. Bergeron, D. Carrier, D. Beauchamp, 1995, Biochimica et biophysica acta.

Pharmacodynamics of antibiotics in fibrin clots.

M. Bergeron, D. Beauchamp, J. Robert, 1993, The Journal of antimicrobial chemotherapy.

Effect of daptomycin on the barotropic behavior of dioleoylphosphatidylglycerol: an infrared spectroscopic investigation

M. Bergeron, D. Carrier, P. Wong, 1996 .

Antiviral efficacy, intracellular uptake and pharmacokinetics of free and liposome‐encapsulated 2',3'-dideoxyinosine

M. Bergeron, D. Beauchamp, S. Perron, 1994, AIDS.

Influence of a circadian-stage-dependent dosing schedule on the pharmacokinetics of isepamicin in humans

M. Bergeron, S. Ohdo, N. Ogawa, 1996, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Ribavirin potentiates the efficacy and toxicity of 2',3'- dideoxyinosine in the murine acquired immunodeficiency syndrome model.

M. Bergeron, M. Tremblay, P. Harvie, 1996, The Journal of pharmacology and experimental therapeutics.

Age-dependent gentamicin experimental nephrotoxicity.

M. Bergeron, D. Beauchamp, P. Gourde, 1992, Journal of Pharmacology and Experimental Therapeutics.

Protective effect of ceftriaxone against the nephrotoxicity of isepamicin administered once daily in rats.

D. Beauchamp, Y. Yoshiyama, M. Kanke, 1998, Biological & pharmaceutical bulletin.